BPC 157: The peptide with big claims and scant evidence STAT Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Should You Try MOTS c and BPC 157 Longevity Peptides? Separating Truth from Hype with Human Data Studies